Top 3 Momentum Stocks to Buy on October 3rd
ByAinvest
Friday, Oct 3, 2025 11:40 am ET1min read
AEG--
Gold Fields Limited, a prominent gold producer with operations in South Africa, Ghana, and Australia, has gained 76.1% over the last three months, significantly outperforming the S&P 500's 7% gain. The company's Momentum Score of A underscores its strong performance. Additionally, the Zacks Consensus Estimate for its current year earnings has increased by 7% over the last 60 days, further bolstering its prospects [1].
Genmab, a biotechnology company specializing in antibody therapeutics for cancer treatment, has also experienced remarkable growth. Its shares have surged 58.2% over the last three months, with a Momentum Score of A. The Zacks Consensus Estimate for its current year earnings has increased by 10.1% over the last 60 days, reflecting investor optimism [1].
Aegon, an international insurance group, has seen its shares rise 11.1% over the last three months, with a Momentum Score of A. The company's Zacks Rank of #1 and the 10.1% increase in the Zacks Consensus Estimate for its current year earnings demonstrate its strong financial health and potential for future growth [1].
Investors should closely monitor these top-ranked stocks with strong momentum characteristics, as they present compelling opportunities for portfolio diversification and potential gains.
GFI--
GMAB--
Gold Fields Limited, Genmab, and Aegon are top-ranked stocks with strong momentum characteristics. Gold Fields Limited gained 76.1% over the last three months and has a Momentum Score of A. Genmab gained 58.2% over the last three months and has a Momentum Score of A. Aegon gained 11.1% over the last three months and has a Momentum Score of A. All three companies have a Zacks Rank of #1 (Strong Buy) and have seen an increase in Zacks Consensus Estimates for their current year earnings.
Investors seeking stocks with robust momentum and strong buy rankings should consider Gold Fields Limited (GFI), Genmab (GMAB), and Aegon (AEG). These companies have shown impressive performance over the last three months and have received a Zacks Rank of #1, indicating a strong buy recommendation.Gold Fields Limited, a prominent gold producer with operations in South Africa, Ghana, and Australia, has gained 76.1% over the last three months, significantly outperforming the S&P 500's 7% gain. The company's Momentum Score of A underscores its strong performance. Additionally, the Zacks Consensus Estimate for its current year earnings has increased by 7% over the last 60 days, further bolstering its prospects [1].
Genmab, a biotechnology company specializing in antibody therapeutics for cancer treatment, has also experienced remarkable growth. Its shares have surged 58.2% over the last three months, with a Momentum Score of A. The Zacks Consensus Estimate for its current year earnings has increased by 10.1% over the last 60 days, reflecting investor optimism [1].
Aegon, an international insurance group, has seen its shares rise 11.1% over the last three months, with a Momentum Score of A. The company's Zacks Rank of #1 and the 10.1% increase in the Zacks Consensus Estimate for its current year earnings demonstrate its strong financial health and potential for future growth [1].
Investors should closely monitor these top-ranked stocks with strong momentum characteristics, as they present compelling opportunities for portfolio diversification and potential gains.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet